FM NOVEMBER 2018 ISSUE - digital edition

More documents

Recommendations

Info

This technology enables users to fit the hearing aid settings themselves, in real-time and in real-world environments without the assistance of a healthcare professional. In authorizing marketing of the Bose device, the FDA reviewed data from clinical studies of 125 patients, which demonstrated that outcomes with self-fitting of the Bose Hearing Aid are comparable on average to those with professional fitting of the same device with respect to the amount of amplification selected, speech in noise testing and overall benefit, the regulatory agency said announcing the approval. Neuro imaging system gets clearance in US The US Food and Drug Administration has okayed a new imaging modality augmented reality (AR) GLOW800 surgical fluorescence for vascular neurosurgery. GLOW800 allows surgeons to observe cerebral anatomy in natural colour, in combination with ICG (Indocyanine Green), augmented by real-time vascular flow in a single image, with full depth perception. It provides the surgeon with a complete view of anatomy and physiology to support crucial decisions and actions during vascular neurosurgery. GLOW800 AR fluorescence is the first of many imaging modalities that will be based on the GLOW AR platform. GLOW AR modalities can be fully integrated into the ARveo digital augmented reality microscope, according to Leica Microsystems, the maker of the device. Certara cloudbased platform to help HCPs Certara has launched BaseCase Portal cloudbased platform that allows for the rapid creation of fullycustomizable mobile apps that connect live to mathematical models and algorithms, and help HCPs optimize treatment for individual patients. BaseCase Portal enables clinicians to use Boston Scientific launches kidney stone retrieval device Boston Scientific Corporation has launched LithoVue Empower Retrieval Deployment Device, designed to be used with the ureteroscope. The device comes with a compatible nitinol retrieval basket to enable urologists to operate a ureteroscope and basket simultaneously when retrieving kidney stones via flexible ureteroscopy (URS). According to Boston Scientific, until now, urologists have traditionally relied on another person to operate the basket used to collect kidney stones during kidney complex scientific models and algorithms that were previously only available in research settings, to guide therapeutic decision-making. The platform keeps a strict separation between the user interface and the underlying mathematical model. This offers many benefits over the old way of doing things in which algorithms typically were hardwired into a website. On BaseCase Portal, algorithms and models can be validated and updated much more easily. BaseCase Portal also features embedded version control and release workflows, and provides an audit trail, allowing a new version of an app to be uploaded as soon as it receives the requisite stone retrieval. Turning a two-person stone basketing procedure into a singleperson procedure provides greater control for the surgeon, decreasing the risk of miscommunication during stone basketing without compromising time. Retrieving kidney stones is one of the most time-consuming steps during ureteroscopy procedures, making this an opportune area to improve physician control, address communication/ coordination challenges and identify time savings, says Boston Scientific. 84 / FUTURE MEDICINE / NOVEMBER 2018
AUGUST 2018/ FUTURE MEDICINE / 85
Page 1:
₹ 250.00 VOL 5 | ISSUE 7 PAGES 10
Page 4 and 5:
Vol 5 Issue 7 November 2018 ₹ 250
Page 6 and 7:
REGULATORY DIAGNOSTICS HEAD & NECK
Page 8 and 9:
news updates Labels on fluoroquinol
Page 10 and 11:
the financial year 2018, it conduct
Page 12 and 13:
egulatory MCI IN DIRE STRAITS The f
Page 14 and 15:
drug resistance TACKLING EMERGING S
Page 16:
Three million surgeries and cancer
Page 19 and 20:
RIGHT DIAGNOSIS, RIGHT TREATMENT AC
Page 21 and 22:
PRICE CONTROL SCENARIO 1,30,000+ 20
Page 23 and 24:
LUNG CARCINOMA: THE COMMONEST CANCE
Page 25 and 26:
oth neoadjuvant and adjuvant settin
Page 27 and 28:
ates (45% vs 28%, respectively) com
Page 29 and 30:
PHOTO: UMESH GOSWAMI Cancer immunot
Page 31 and 32:
Oncologists, according to Dr Rajend
Page 33 and 34: ETED VACCINE THERAPY ON WAY in prec
Page 35 and 36: showed that rivaroxaban vascular do
Page 37 and 38: 1:1 to dacomitinib or gefitinib. A
Page 39 and 40: While Voretigene has passed clinica
Page 41 and 42: 1 2 3 4 The tumour was subtracted d
Page 43 and 44: occurring in less than 1% of the ge
Page 46 and 47: Ziehl-Neelsen staining of smears an
Page 48 and 49: case reports BRACHYTHERAPY FOR BRAI
Page 50 and 51: education NEUBERG-ANAND TO OFFER PO
Page 52: education BRIDGE COURSE AT CROSSROA
Page 55 and 56: to start the communication with a q
Page 57 and 58: DNA (mtDNAs) in a heteroplasmic mam
Page 60 and 61: policy MENTAL HEALTH CARE ACT 2017
Page 62 and 63: of the right of individual to seek
Page 64 and 65: COPD technology EBV INTERVENTION IN
Page 66: hospital news Continental Hospital
Page 69 and 70: in insurance coverage will lead to
Page 71 and 72: Environmental noise is an important
Page 73 and 74: BY SOURCE To reduce health effects,
Page 75 and 76: Hypertension is a common condition
Page 77 and 78: therapies for sepsis that reduce it
Page 80: otator cuff tears has been shown to
Page 83: Zeiss laser tech to treat astigmati
Page 88: events MVR CANCON2018 debates trans
Page 91 and 92: science in India through research a
Page 93 and 94: will make a double strand break of
Page 95 and 96: ook review A REBUTTAL TO VACCINE NA
Page 98 and 99: DON’T RESTRICT YOURSELF TO ‘DOT
show all

FM NOVEMBER 2018 ISSUE - digital edition

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?